ClinicalTrials.govpublic full text
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
type 2 diabetes, diabetes, exenatide, insulin glargine, lilly, amylin, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981999
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.